Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083

By sjmartinez • November 24, 2024

Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF, Jennings A, Gomez-Feliciano K, McCauley M, Grinsztejn B, Landovitz RJ; for HPTN 083 Study Team. Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083. Clin Infect Dis. 2024 Nov 23:ciae572. doi: 10.1093/cid/ciae572. Epub ahead of print. PMID: 39579334.

Tags: bacterial sexually transmitted infections, CAB-LA, efficacy, HIV prevention, Infectious Diseases, Long-acting PrEP, Publications

Early Outcomes of Mental Health Screening Integrated Into Routine HIV Care in Malawi

Chikuse E, Hagstrom C, Smith D, Banda T, Chimbaka H, Nkhoma Z, Samuko M, Lichenya J, Hoffman R, Njala J, Phiri S, Phiri K, van[...]

Health System Factors Influencing the Integration of Pre-Exposure Prophylaxis into Antenatal and Postnatal Clinic Services in Cape Town, South Africa

Court L, Nelson A, Taliep R, Dean SS, Mvududu R, Knight L, Dovel K, Coates T, Myer L, Davey DLJ. Health System Factors Influencing the[...]

Comparison of basic lymphocyte phenotype results between a diagnostic and a research laboratory

Aziz N, LaBelle E, Jamieson BD, Mimiaga MJ, Detels R. Comparison of basic lymphocyte phenotype results between a diagnostic and a research laboratory. Lab Med.[...]